GL1X · GenesisL1 explorer

Research workbench

Crystal structure of RV2671 from mycobacterium tuberculosis in complex with NADP+ and trimethoprim

Analyse Crystal structure of RV2671 from mycobacterium tuberculosis in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4XT7
Type
protein
Length
246 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RV2671
UniProt
P71968
Ligands
NAP, TOP
Pockets
3 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 28% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARV2671protein24628% helix, 22% strandP71968

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • TOP · Trimethoprim · ligand · chains A
  • GOL · Glycerol · additive · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12970.620.7946NAP, TOP, GOL
21700.470.7624empty
31220.400.7419empty

Compared structures

  • 4XT7 · Crystal structure of Rv2671 from Mycobacterium tuberculosis in complex with NADP+ and… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.